Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in TMDX — TransMedics Group, Inc.

CIK 861177 NEW YORK, NY
Back to TMDX Full portfolio

Position in TMDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26,451,761
-$66,946,218 QoQ
Shares Held
398,250
-57.6% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 372 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 24% Shared 0% None 76%

Common Shares in TMDX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. TMDX ranks #13 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
 2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in TMDX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,451,761 398,250
2026-03-31 $93,397,979 939,523
2025-12-31 $121,270,204 996,878
2025-09-30 $119,996,999 1,069,492
2025-06-30 $128,070,004 955,675
2025-03-31 $209,448,152 3,113,082
2024-12-31 $56,307,409 903,086
2024-09-30 $54,104,084 344,612
2024-06-30 $53,985,066 358,419
2024-03-31 $3,166,848 42,830
2023-12-31 $3,380,569 42,830
2023-09-30 $2,580,584 47,134
2023-06-30 $3,457,370 41,169
2023-03-31 $3,117,726 41,169
2022-12-31 $2,420,780 39,222
2022-09-30 $1,287,134 30,837
2022-06-30 $1,029,702 32,741
2022-03-31 $882,041 32,741
2021-12-31 $571,541 29,830
2021-09-30 $987,074 29,830
2021-06-30 $789,053 23,781